<DOC>
	<DOC>NCT02144402</DOC>
	<brief_summary>The primary objective is to determine if the weight gain of healthy term infants fed a commercially available term infant formula supplemented with DHASCO® is similar to that of infants fed the same formula supplemented with a new product, DHASCO®-B.</brief_summary>
	<brief_title>Growth of Healthy Term Infants Fed Formula Containing DHA-B</brief_title>
	<detailed_description />
	<criteria>full term infant (gestational age 3742 weeks) birth weight &gt; or equal to 2500 g singleton infant &lt; or equal to 14 days of age in good health parent must be &gt;21 years of age parental consent congenital malformation or genetic disorder metabolic anomalies maternal infectious diseases, alcoholism, substance abuse mothers with gestational diabetes participation in another clinical study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>14 Days</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>